Your browser doesn't support javascript.
loading
Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.
Fishel Bartal, Michal; Ashby Cornthwaite, Joycelyn A; Ghafir, Danna; Ward, Clara; Ortiz, Gladys; Louis, Aleaha; Cornthwaite, John; Chauhan, Suneet S P; Sibai, Baha M.
Affiliation
  • Fishel Bartal M; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Ashby Cornthwaite JA; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Ghafir D; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Ward C; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Ortiz G; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Louis A; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Cornthwaite J; Department of Earth, Environmental and Planetary Science, Rice University, Houston, Texas.
  • Chauhan SSP; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Sibai BM; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
Am J Perinatol ; 40(5): 461-466, 2023 04.
Article in En | MEDLINE | ID: mdl-35858653
ABSTRACT

OBJECTIVE:

The international consensus on continuous glucose monitoring (CGM) recommends time in range (TIR) target of >70% for pregnant people. Our aim was to compare outcomes between pregnant people with TIR ≤ versus >70%. STUDY

DESIGN:

This study was a retrospective study of all people using CGM during pregnancy from January 2017 to May 2021 at a tertiary care center. All people with pregestational diabetes who used CGM and delivered at our center were included in the analysis. Primary neonatal outcome included any of the following large for gestational age, neonatal intensive care unit (NICU) admission, need for intravenous (IV) glucose, or respiratory distress syndrome (RDS). Maternal outcomes included hypertensive disorders of pregnancy and delivery outcomes. Logistic regression was used to estimate unadjusted and adjusted odds ratios (aORs) with 95% confidence intervals (CIs).

RESULTS:

Of 78 people managed with CGM, 65 (80%) met inclusion criteria. While 33 people (50.1%) had TIR ≤70%, 32 (49.2%) had TIR >70%. People with TIR ≤70% were more likely to be younger, have a lower body mass index, and have type 1 diabetes than those with TIR >70%. After multivariable regression, there was no difference in the composite neonatal outcome between the groups (aOR 0.56, 95% CI 0.16-1.92). However, neonates of people with TIR ≤70% were more likely to be admitted to the NICU (p = 0.035), to receive IV glucose (p = 0.005), to have RDS (p = 0.012), and had a longer hospital stay (p = 0.012) compared with people with TIR >70%. Furthermore, people with TIR ≤70% were more likely to develop hypertensive disorders (p = 0.04) than those with TIR >70%.

CONCLUSION:

In this cohort, the target of TIR >70% was reached in about one out of two people with diabetes using CGM, which correlated with a reduction in neonatal and maternal complications. KEY POINTS · Among people with diabetes, 50% reached the recommended time in range using CGM.. · Time in range >70% was associated with reducing the rate of some neonatal complications.. · Time in range ≤70% was associated with increased risk for adverse maternal outcomes..
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Pregnancy Outcome / Diabetes Mellitus, Type 1 Type of study: Observational_studies Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Am J Perinatol Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pregnancy Outcome / Diabetes Mellitus, Type 1 Type of study: Observational_studies Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Am J Perinatol Year: 2023 Type: Article